184 related articles for article (PubMed ID: 31812935)
1. Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis.
Mayinger M; Kraft J; Lohaus N; Weller M; Schanne D; Heitmann J; Willmann J; Wilke L; Krayenbuehl J; Tanadini-Lang S; Guckenberger M; Andratschke N
Eur J Cancer; 2020 Jan; 124():194-203. PubMed ID: 31812935
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis.
Leskinen S; Shah HA; Yaffe B; Schneider SJ; Ben-Shalom N; Boockvar JA; D'Amico RS; Wernicke AG
J Neurooncol; 2023 Jul; 163(3):515-527. PubMed ID: 37395975
[TBL] [Abstract][Full Text] [Related]
3. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study.
Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC
Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802
[TBL] [Abstract][Full Text] [Related]
7. Treatment Planning and Delivery of Whole Brain Irradiation with Hippocampal Avoidance in Rats.
Cramer CK; Yoon SW; Reinsvold M; Joo KM; Norris H; Hood RC; Adamson JD; Klein RC; Kirsch DG; Oldham M
PLoS One; 2015; 10(12):e0143208. PubMed ID: 26636762
[TBL] [Abstract][Full Text] [Related]
8. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
[TBL] [Abstract][Full Text] [Related]
9. Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients.
Cho Y; Lee J; Lee IJ; Kim JW; Baek JG; Jung DM; Cho BC; Hong MH; Kim HR; Lee CG; Yoon HI
Sci Rep; 2021 Apr; 11(1):7435. PubMed ID: 33795826
[TBL] [Abstract][Full Text] [Related]
10. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients With Brain Metastasis.
Wang B; Fu S; Huang Y; Liu L; Liang Y; An W; Fan Y; Zhao Y
Technol Cancer Res Treat; 2021; 20():15330338211034269. PubMed ID: 34396867
[TBL] [Abstract][Full Text] [Related]
12. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCI.
de Ruiter MB; Groot PFC; Deprez S; Pullens P; Sunaert S; de Ruysscher D; Schagen SB; Belderbos J
Neuro Oncol; 2023 Jan; 25(1):167-176. PubMed ID: 35640975
[TBL] [Abstract][Full Text] [Related]
14. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
Kundapur V; Ellchuk T; Ahmed S; Gondi V
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
[TBL] [Abstract][Full Text] [Related]
15. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
16. Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.
Korkmaz Kirakli E; Oztekin O
Technol Cancer Res Treat; 2017 Dec; 16(6):1202-1208. PubMed ID: 29332467
[TBL] [Abstract][Full Text] [Related]
17. Volumetric-modulated arc therapy (VMAT) for whole brain radiotherapy: not only for hippocampal sparing, but also for reduction of dose to organs at risk.
Sood S; Pokhrel D; McClinton C; Lominska C; Badkul R; Jiang H; Wang F
Med Dosim; 2017 Winter; 42(4):375-383. PubMed ID: 28822604
[TBL] [Abstract][Full Text] [Related]
18. Sparing of the neural stem cell compartment during whole-brain radiation therapy: a dosimetric study using helical tomotherapy.
Marsh JC; Godbole RH; Herskovic AM; Gielda BT; Turian JV
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):946-54. PubMed ID: 20472348
[TBL] [Abstract][Full Text] [Related]
19. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging.
Wang BH; Hua W; Gu X; Wang XL; Li J; Liu LQ; Huang YX
Australas Phys Eng Sci Med; 2015 Dec; 38(4):767-75. PubMed ID: 26577714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]